{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:08:03Z","timestamp":1786993683756,"version":"build-2736575974"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"am","delay-in-days":305,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.lfs.2022.120594","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T11:44:11Z","timestamp":1651232651000},"page":"120594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Necroptosis modulation by cisplatin and sunitinib in hepatocellular carcinoma cell line"],"prefix":"10.1016","volume":"301","author":[{"given":"Sarah M.","family":"El-Demiry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El-Yamany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad M.","family":"El-Gendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.A.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona M.","family":"Saber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2022.120594_bb0005","unstructured":"Global Cancer Observatory, (n.d.)."},{"key":"10.1016\/j.lfs.2022.120594_bb0010","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s40471-019-00188-3","article-title":"The changing epidemiology of primary liver cancer","volume":"6","author":"Petrick","year":"2019","journal-title":"Curr. Epidemiol. Rep."},{"key":"10.1016\/j.lfs.2022.120594_bb0015","series-title":"Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases Purpose and Scope","volume":"68","author":"Marrero","year":"2018"},{"key":"10.1016\/j.lfs.2022.120594_bb0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1148\/radiol.11110144","article-title":"Local-regional treatment of hepatocellular carcinoma","volume":"262","author":"Lencioni","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.lfs.2022.120594_bb0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.13005\/bpj\/1608","article-title":"Review on pharmacology of cisplatin: clinical use, toxicity and mechanism of resistance of cisplatin","volume":"12","author":"Aldossary","year":"2019","journal-title":"Biomed. Pharmacol. J."},{"key":"10.1016\/j.lfs.2022.120594_bb0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2018.03.009","article-title":"Cisplatin-induced gastrointestinal toxicity: An update on possible mechanisms and on available gastroprotective strategies","volume":"827","author":"F","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120594_bb0035","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.7150\/jca.25056","article-title":"Identifying the best anticancer agent combination in TACE for HCC patients: a network meta-analysis","volume":"9","author":"Guo","year":"2018","journal-title":"J. Cancer"},{"key":"10.1016\/j.lfs.2022.120594_bb0040","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tox.2016.10.001","article-title":"An integrative view of cisplatin-induced renal and cardiac toxicities: molecular mechanisms, current treatment challenges and potential protective measures","volume":"371","author":"Gj","year":"2016","journal-title":"Toxicology."},{"key":"10.1016\/j.lfs.2022.120594_bb0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/carcin\/bgs317","article-title":"MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cells","volume":"34","author":"JP","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lfs.2022.120594_bb0050","doi-asserted-by":"crossref","first-page":"22219","DOI":"10.18632\/oncotarget.7924","article-title":"Key roles of necroptotic factors in promoting tumor growth","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2022.120594_bb0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nature17403","article-title":"The necrosome promotes pancreatic oncogenesis via CXCL1 and mincle-induced immune suppression","volume":"532","author":"Seifert","year":"2016","journal-title":"Nature"},{"issue":"562","key":"10.1016\/j.lfs.2022.120594_bb0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41586-018-0519-y","article-title":"Necroptosis microenvironment directs lineage commitment in liver cancer","volume":"5627725","author":"Seehawer","year":"2018","journal-title":"Nat."},{"key":"10.1016\/j.lfs.2022.120594_bb0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1042\/BJ20071643","article-title":"Hydrogen peroxide mediates the radiation-induced mutator phenotype in mammalian cells","volume":"413","author":"Dayal","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.lfs.2022.120594_bb0070","first-page":"3230","article-title":"A mutator phenotype in cancer","volume":"61","author":"Loeb","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2022.120594_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0027-5107(01)00091-4","article-title":"The contribution of endogenous sources of DNA damage to the multiple mutations in cancer","volume":"477","author":"Jackson","year":"2001","journal-title":"Mutat. Res."},{"key":"10.1016\/j.lfs.2022.120594_bb0080","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1136\/gutjnl-2020-321767","article-title":"RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease","volume":"70","author":"Afonso","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2022.120594_bb0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.freeradbiomed.2020.12.449","article-title":"Role of necroptosis in chronic hepatic inflammation and fibrosis in a mouse model of increased oxidative stress","volume":"164","author":"Mohammed","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2022.120594_bb0090","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s11357-019-00131-w","article-title":"The potential role of necroptosis in inflammaging and aging","volume":"41","author":"Royce","year":"2019","journal-title":"GeroScience."},{"key":"10.1016\/j.lfs.2022.120594_bb0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-405881-1.00002-1","article-title":"Reactive oxygen species in the activation of MAP kinases","volume":"528","author":"Y","year":"2013","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.lfs.2022.120594_bb0100","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.3390\/ijms20071779","article-title":"MAPK\/ERK signaling in regulation of renal differentiation","volume":"20","author":"Kurtzeborn","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2022.120594_bb0105","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","article-title":"Molecular therapies and precision medicine for hepatocellular carcinoma","volume":"15","author":"JM","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.lfs.2022.120594_bb0110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/cld.810","article-title":"Mechanisms of action of drugs effective in hepatocellular carcinoma","volume":"14","author":"Sarcognato","year":"2019","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.lfs.2022.120594_bb0115","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nrd2380","article-title":"Molecular basis for sunitinib efficacy and future clinical development","volume":"6","author":"S.","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2022.120594_bb0120","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/PPO.0b013e3181af5e35","article-title":"Development of sunitinib in hepatocellular carcinoma: rationale, early clinical experience, and correlative studies","volume":"15","author":"Zhu","year":"2009","journal-title":"Cancer J."},{"key":"10.1016\/j.lfs.2022.120594_bb0125","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1158\/1535-7163.MCT-10-1124","article-title":"New insights into molecular mechanisms of sunitinib-associated side effects","volume":"10","author":"G.","year":"2011","journal-title":"Mol. Cancer Ther."},{"issue":"12","key":"10.1016\/j.lfs.2022.120594_bb0130","first-page":"1","article-title":"Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy","volume":"121","author":"Qin","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.lfs.2022.120594_bb0135","article-title":"Hepatocellular carcinoma: novel molecular targets in carcinogenesis for future therapies","volume":"2014","author":"G","year":"2014","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.lfs.2022.120594_bb0140","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1172\/JCI84386","article-title":"Dual modulation of MCL-1 and mTOR determines the response to sunitinib","volume":"127","author":"Elgendy","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2022.120594_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102699","article-title":"Severe metabolic alterations in liver cancer lead to ERK pathway activation and drug resistance","volume":"54","author":"Nwosu","year":"2020","journal-title":"EBioMedicine."},{"key":"10.1016\/j.lfs.2022.120594_bb0150","doi-asserted-by":"crossref","first-page":"738","DOI":"10.2174\/156800909789271530","article-title":"Sunitinib (SUTENT, SU11248) suppresses tumor growth and induces apoptosis in xenograft models of human hepatocellular carcinoma","volume":"9","author":"Huynh","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.lfs.2022.120594_bb0155","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/MEG.0b013e328350916f","article-title":"Antitumor effect of vascular endothelial growth factor inhibitor sunitinib in preclinical models of hepatocellular carcinoma","volume":"24","author":"Bagi","year":"2012","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2022.120594_bb0160","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3389\/fphar.2017.00367","article-title":"Hepatocellular toxicity associated with tyrosine kinase inhibitors: mitochondrial damage and inhibition of glycolysis","author":"Paech","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120594_bb0165","first-page":"647","article-title":"Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors; retrospective multicenter experience","volume":"60","author":"Kefeli","year":"2013","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.lfs.2022.120594_bb0170","article-title":"Sunitinib monotherapy in patients with advanced hepatocellular carcinoma (HCC): insights from a multidisciplinary phase II study","volume":"26","author":"Zhu","year":"2008"},{"key":"10.1016\/j.lfs.2022.120594_bb0175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000320363","article-title":"Sunitinib in patients with advanced hepatocellular carcinoma after progression under sorafenib treatment","volume":"79","author":"W\u00f6rns","year":"2010","journal-title":"Oncology"},{"key":"10.1016\/j.lfs.2022.120594_bb0180","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/791406","article-title":"Synergistic effect between cisplatin and sunitinib malate on human urinary bladder-cancer cell lines","volume":"2013","author":"Arantes-Rodrigues","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2022.120594_bb0185","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1210\/jc.2013-2574","article-title":"Synergistic cooperation between sunitinib and cisplatin promotes apoptotic cell death in human medullary thyroid cancer","volume":"99","author":"Lopergolo","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2022.120594_bb0190","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.lungcan.2010.01.016","article-title":"Sunitinib in combination with gemcitabine plus cisplatin for advanced non-small cell lung cancer: a phase I dose-escalation study","volume":"70","author":"Reck","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lfs.2022.120594_bb0195","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s10637-012-9830-x","article-title":"A phase I, dose-finding study of sunitinib combined with cisplatin and 5-fluorouracil in patients with advanced gastric cancer","volume":"31","author":"G\u00f3mez-Mart\u00edn","year":"2013","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.lfs.2022.120594_bb0200","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/s-0038-1629924","article-title":"The receptor interacting protein kinases in the liver","volume":"38","author":"L","year":"2018","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.lfs.2022.120594_bb0205","doi-asserted-by":"crossref","first-page":"694","DOI":"10.4149\/neo_2018_180710N466","article-title":"Receptor interacting protein kinase 3 promotes cisplatin-induced necroptosis in apoptosis-resistant HepG2\/DDP cells","volume":"66","author":"Zhang","year":"2019","journal-title":"Neoplasma"},{"key":"10.1016\/j.lfs.2022.120594_bb0210","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molcel.2014.03.003","article-title":"Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3","volume":"54","author":"H","year":"2014","journal-title":"Mol. Cell."},{"key":"10.1016\/j.lfs.2022.120594_bb0215","article-title":"Necroptosis: a crucial pathogenic mediator of human disease","volume":"4","author":"Me","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.lfs.2022.120594_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-801430-1.00001-9","article-title":"Assays for necroptosis and activity of RIP kinases","volume":"545","author":"A","year":"2014","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.lfs.2022.120594_bb0225","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ccell.2015.10.001","article-title":"NEMO prevents steatohepatitis and hepatocellular carcinoma by inhibiting RIPK1 kinase activity-mediated hepatocyte apoptosis","volume":"28","author":"Kondylis","year":"2015","journal-title":"Cancer Cell."},{"key":"10.1016\/j.lfs.2022.120594_bb0230","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1172\/JCI92508","article-title":"Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis","volume":"127","author":"Van","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"18","key":"10.1016\/j.lfs.2022.120594_bb0235","first-page":"1","article-title":"The role of necroptosis in cancer biology and therapy","volume":"181","author":"Gong","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.lfs.2022.120594_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112140","article-title":"Metformin dampens cisplatin cytotoxicity on leukemia cells after incorporation into cubosomal nanoformulation","volume":"143","author":"Saber","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2022.120594_bb0245","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4727-5","article-title":"Targeting colorectal cancer cell metabolism through development of cisplatin and metformin nano-cubosomes","volume":"18","author":"Saber","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lfs.2022.120594_bb0250","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.7150\/thno.29093","article-title":"Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5","volume":"9","author":"Giuliano","year":"2019","journal-title":"Theranostics."},{"key":"10.1016\/j.lfs.2022.120594_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2019.152281","article-title":"Mitochondrial oxidative stress plays a critical role in the cardiotoxicity of sunitinib: running title: sunitinib and oxidative stress in hearts","volume":"426","author":"Bouitbir","year":"2019","journal-title":"Toxicology"},{"key":"10.1016\/j.lfs.2022.120594_bb0260","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.21873\/anticanres.11200","article-title":"FoxO3a is essential for the antiproliferative and apoptogenic effects of sunitinib in MDA-MB231 cell line","volume":"36","author":"Korashy","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.lfs.2022.120594_bb0265","article-title":"Crizotinib and sunitinib induce hepatotoxicity and mitochondrial apoptosis in L02 cells via ROS and Nrf2 signaling pathway","volume":"12","author":"Guo","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120594_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081162","article-title":"Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions","volume":"8","author":"Marullo","year":"2013","journal-title":"PLoS.One."},{"key":"10.1016\/j.lfs.2022.120594_bb0275","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jat.1284","article-title":"Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver","volume":"28","author":"Martins","year":"2008","journal-title":"J. Appl. Toxicol."},{"issue":"8","key":"10.1016\/j.lfs.2022.120594_bb0280","first-page":"1","article-title":"Cisplatin generates oxidative stress which is accompanied by rapid shifts in central carbon metabolism","volume":"81","author":"Yu","year":"2018","journal-title":"Sci. Reports"},{"key":"10.1016\/j.lfs.2022.120594_bb0285","doi-asserted-by":"crossref","first-page":"694","DOI":"10.4149\/neo_2018_180710N466","article-title":"Receptor interacting protein kinase 3 promotes cisplatin-induced necroptosis in apoptosis-resistant HepG2\/DDP cells","volume":"66","author":"B","year":"2019","journal-title":"Neoplasma"},{"key":"10.1016\/j.lfs.2022.120594_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169767","article-title":"Radiation induced apoptosis of murine bone marrow cells is independent of early growth response 1 (EGR1)","volume":"12","author":"Oben","year":"2017","journal-title":"PLoS One."},{"key":"10.1016\/j.lfs.2022.120594_bb0295","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/annonc\/mdv072","article-title":"A randomized phase II study of the MEK1\/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)","volume":"26","author":"Blumenschein","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lfs.2022.120594_bb0300","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1158\/1541-7786.MCR-18-1332","article-title":"Intrinsic resistance to MEK inhibition through BET protein-mediated kinome reprogramming in NF1-deficient ovarian cancer","volume":"17","author":"Kurimchak","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.lfs.2022.120594_bb0305","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/JHC.S168953","article-title":"Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date","volume":"6","author":"Personeni","year":"2019","journal-title":"J. Hepatocell. Carcinoma."},{"key":"10.1016\/j.lfs.2022.120594_bb0310","article-title":"A small molecule targeting human MEK1\/2 enhances ERK and p38 phosphorylation under oxidative stress or with phenothiazines","volume":"11","author":"Otr\u0119ba","year":"2021","journal-title":"Life (BaselSwitzerland)"},{"key":"10.1016\/j.lfs.2022.120594_bb0315","doi-asserted-by":"crossref","first-page":"6428","DOI":"10.1038\/onc.2010.380","article-title":"An ERK-dependent pathway to noxa expression regulates apoptosis by platinum-based chemotherapeutic drugs","volume":"29","author":"Sheridan","year":"2010","journal-title":"Oncogene"},{"issue":"108","key":"10.1016\/j.lfs.2022.120594_bb0320","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/bjc.2012.539","article-title":"Effect of sorafenib combined with cytostatic agents on hepatoblastoma cell lines and xenografts","volume":"1082","author":"Eicher","year":"2013","journal-title":"Br. J. Cancer"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522002946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522002946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:58:53Z","timestamp":1758401933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522002946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":64,"alternative-id":["S0024320522002946"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120594","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Necroptosis modulation by cisplatin and sunitinib in hepatocellular carcinoma cell line","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120594","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120594"}}